drugset / Trial / NCT01985594

Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial

NCT01985594

Phase 2 Unknown 32 enrolled nor zila hassan malek
RandomizedParallel-groupSingle-blindPrevention

Summary

RESEARCH HYPOTHESIS -Incidence of preterm delivery is lower in women treated with oral micronized progesterone (Utrogestan) as acute tocolysis agent compare to Nifedipine group with fewer maternal side effect

Timeline

Start
2013-11
Primary completion
2014-07
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nifedipine Other / unclassified 10 mg Oral
Comparator Progesterone Other / unclassified 400 mg Oral

Indications

No indication recorded.